Otonomy to Participate in Two Upcoming Investor Conferences
September 02, 2021 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that...
Otonomy Appoints Jill Broadfoot to Board of Directors
August 19, 2021 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...
InnerScope Hearing Technologies (OTC: INND) Upgraded to Pink Current by OTC Markets
July 29, 2021 08:00 ET
|
InnerScope Hearing Technologies, Inc.
ROSEVILLE, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InnerScope Hearing Technologies Inc. (OTC: INND) ("InnerScope" or the “Company”), an emerging and disruptive leader in the...
Otonomy to Report Second Quarter 2021 Financial Results and Provide Corporate Update
July 28, 2021 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, July 28, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...
Silencil Reviews: Negative Side Effects or Real Ingredients?
April 22, 2021 18:18 ET
|
Marketing By Kevin
New York, NY, April 22, 2021 (GLOBE NEWSWIRE) -- Silencil is a daily solution for tinnitus sufferers and specializes in eradicating inflammation that can commonly occur in specific parts of the...
Synapse XT Reviews – New Tinnitus Supplement - By ProductWorld
April 19, 2021 19:41 ET
|
ProductWorld
New York, NY, April 19, 2021 (GLOBE NEWSWIRE) -- Synapse XT is an organic dietary supplement that is entirely natural devoid of chemicals that provide tinnitus relief, enhances brain health,...
Otonomy Announces Proposed Public Offering
April 07, 2021 16:06 ET
|
Otonomy, Inc.
SAN DIEGO, April 07, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that...
Otonomy to Present at the Needham Virtual Healthcare Conference
April 06, 2021 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, April 06, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced its...
Otonomy Announces Presentation of OTO-313 Clinical Results at American Neurotology Society Annual Meeting
April 05, 2021 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...
Silencil Reviews: Negative Side Effects or Real Tinnitus Aid
April 04, 2021 06:00 ET
|
Marketing By Kevin
Chicago, IL, April 04, 2021 (GLOBE NEWSWIRE) -- Silencil is a daily supplement for tinnitus to alleviate the ringing in the ears that is caused by inflammation in the brain. The formula, found...